AU2003269027A1 - Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same - Google Patents

Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same

Info

Publication number
AU2003269027A1
AU2003269027A1 AU2003269027A AU2003269027A AU2003269027A1 AU 2003269027 A1 AU2003269027 A1 AU 2003269027A1 AU 2003269027 A AU2003269027 A AU 2003269027A AU 2003269027 A AU2003269027 A AU 2003269027A AU 2003269027 A1 AU2003269027 A1 AU 2003269027A1
Authority
AU
Australia
Prior art keywords
alpha
same
pharmaceutical compositions
reductase inhibitors
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269027A
Other versions
AU2003269027A8 (en
Inventor
Jerome Besse
Laurence Besse
Brigitte Taravella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Besins International Belgique
Galenix Innovations Sas
Original Assignee
Besins International Belgique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins International Belgique filed Critical Besins International Belgique
Publication of AU2003269027A1 publication Critical patent/AU2003269027A1/en
Publication of AU2003269027A8 publication Critical patent/AU2003269027A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003269027A 2002-07-16 2003-07-15 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same Abandoned AU2003269027A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0208964 2002-07-16
FR0208964A FR2842421B1 (en) 2002-07-16 2002-07-16 NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON 5-ALPHA-REDUCTASE INHIBITORS AND USES THEREOF
PCT/FR2003/002237 WO2004006937A2 (en) 2002-07-16 2003-07-15 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same

Publications (2)

Publication Number Publication Date
AU2003269027A1 true AU2003269027A1 (en) 2004-02-02
AU2003269027A8 AU2003269027A8 (en) 2004-02-02

Family

ID=29797452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269027A Abandoned AU2003269027A1 (en) 2002-07-16 2003-07-15 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same

Country Status (3)

Country Link
AU (1) AU2003269027A1 (en)
FR (1) FR2842421B1 (en)
WO (1) WO2004006937A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745796A1 (en) * 2005-07-19 2007-01-24 Bionorica Research GmbH Compound preparation for treating prostate carcinoma
KR101809908B1 (en) 2014-07-21 2018-01-25 주식회사 종근당 Pharmaceutical composition comprising 5-α reductase inhibitor
CN110638777A (en) * 2019-10-24 2020-01-03 仁和堂药业有限公司 Finasteride tablet and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08157370A (en) * 1994-12-06 1996-06-18 Banyu Pharmaceut Co Ltd Sustained release composition containing finasteride
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
FR2842421B1 (en) 2004-10-15
AU2003269027A8 (en) 2004-02-02
WO2004006937A3 (en) 2004-04-08
WO2004006937A2 (en) 2004-01-22
FR2842421A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
AU2003280188A1 (en) Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
AU2003237987A1 (en) Novel sweetener compositions and methods of use
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2003303231A1 (en) Benzoxazines and derivatives thereof as inhibitors of pi3ks
AU2003263345A1 (en) Sulphonamide derivatives and their use as tace inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003220361A1 (en) Benzamides and compositions benzamides for use as fungizide
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003243603A1 (en) Methods and compositions involving aldose reductase inhibitors
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003285677A1 (en) Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors
AU2003269421A1 (en) Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
AU2003275268A1 (en) Hemostatic compositions and methods
AU2003201071A1 (en) Stable pharmaceutical compositions comprising ace inhibitor(s)
AU2003291828A1 (en) Microspheres and related processes and pharmaceutical compositions
AU2003239868A1 (en) Sunscreen compositions and methods of use thereof
AU2003233445A1 (en) Antimicrobial compositions and methods of use
AU2003304240A1 (en) INHIBITION OF EGR-1 EXPRESSION BY RPAR-Gamma AGONISTA AND RELATED COMPOSITIONS AND METHODS
AU2003269027A1 (en) Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same
AU2003301819A1 (en) Compositions and methods for prevention of photoaging
AU2003294684A1 (en) Ketoprofen compositions and methods of making them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase